Showing results (41-50 of 71) with videos related to
Sort By:
Pageof 8
Mediators of Inflammation|September 1, 2022
Expression of Thymic Stromal Lymphopoietin in Immune-Related DermatosesSi-Zhe Li, Xin-Xing Jin, Yin Shan, et al.Journal of Immunology Research|October 8, 2020
Thymic Stromal Lymphopoietin Is Implicated in the Pathogenesis of Bullous Pemphigoid by Dendritic CellsSi-Zhe Li, Xin-Xing Jin, Xiao-Lei Ge, et al.International Immunopharmacology|January 7, 2024
Comparison of gut microbiota dysbiosis between pemphigus vulgaris and bullous pemphigoidZiying Han, Yue Fan, Qingyang Wu, et al.Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|August 9, 2008
[Incidence of seroresistance of syphilis and its relevant factors]Lin-Na Wang, Ya-Gang Zuo, Yong-Xin Liu, et al.Experimental Dermatology|November 1, 2023
Identification of gut microbiota dysbiosis in bullous pemphigoid under different disease activityXiaomin Hu, Qingyang Wu, Yue Fan, et al.Clinical, Cosmetic and Investigational Dermatology|March 20, 2026
A Single-Center Profile of Pemphigus in China: Significant Diagnostic Delay and Evolving Treatment PatternsHanlin Zhang, Dianmo Li, Yuqiao Zhang, et al.Biomolecules|July 27, 2024
Gut Microbiome Dysbiosis in Patients with Pemphigus and Correlation with Pathogenic AutoantibodiesSi-Zhe Li, Qing-Yang Wu, Yue Fan, et al.Journal of Inflammation Research|May 7, 2026
Corticosteroid-Sparing Control of Bullous Pemphigoid with Dupilumab and Tripterygium Glycosides: A Real-World Cohort with Longitudinal TranscriptomicsSi-Hang Wang, Si-Zhe Li, Yi-Ran Li, et al.Frontiers in Immunology|August 14, 2023
Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell typesTianmeng Yan, Yinghan Xie, Yuhua Liu, et al.Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|May 11, 2010
[Analysis of 1125 syphilis cases]Jun Li, Lin-na Wang, He-yi Zheng, et al.Pageof 8